Status:

WITHDRAWN

Sulindac for Patients With AML

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Acute Myeloid Leukemia

Eligibility:

All Genders

60+ years

Phase:

PHASE2

Brief Summary

This research study is a Phase II clinical trial. Phase II clinical trials test the effectiveness of an investigational drug to learn whether the drug is effective in treating a specific cancer. "Inve...

Detailed Description

To determine if you are eligible to participate in this study you will be asked to undergo some screening tests or procedures. Many of these tests and procedures are likely to be part of regular cance...

Eligibility Criteria

Inclusion

  • Pathologically confirmed newly diagnosed acute myelogenous leukemia in complete remission following induction chemotherapy

Exclusion

  • Plan for consolidative stem cell transplant in CR1 at the time of enrollment
  • Previous history of coronary artery disease or heart failure
  • Previous history of major allergic reaction to aspirin or other non-steroidal anti-inflammatory drugs
  • Previous history of gastric or duodenal ulceration
  • Diagnosis of acute promyelocytic leukemia
  • Diagnosis of acute bilineal/biphenotypic leukemia
  • History of a different malignancy unless disease free for at least 5 years or diagnosed and treated for cervical cancer in situ, basal or squamous cell carcinoma of the skin
  • Uncontrolled intercurrent illness that would limit compliance with study requirements
  • Disseminated intravascular coagulation
  • HIV positive on combination anti-retroviral therapy
  • Known active hepatitis B or C
  • History of coronary artery disease
  • Current or history of congestive heart failure
  • History of ventricular arrhythmia
  • Patients with mental deficits or psychiatric conditions that preclude them form giving informed consent and following protocol
  • Pregnant

Key Trial Info

Start Date :

January 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01843179

Start Date

January 1 2014

End Date

January 1 2014

Last Update

February 17 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02115

Sulindac for Patients With AML | DecenTrialz